New York State Common Retirement Fund Alnylam Pharmaceuticals, Inc. Transaction History
New York State Common Retirement Fund
- $75.2 Billion
- Q2 2025
A detailed history of New York State Common Retirement Fund transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 63,272 shares of ALNY stock, worth $27.2 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
63,272
Previous 64,272
1.56%
Holding current value
$27.2 Million
Previous $17.4 Million
18.88%
% of portfolio
0.03%
Previous 0.03%
Shares
34 transactions
Others Institutions Holding ALNY
# of Institutions
742Shares Held
115MCall Options Held
584KPut Options Held
672K-
Capital World Investors Los Angeles, CA16.8MShares$7.22 Billion0.83% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$5.72 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$4.1 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.19MShares$3.09 Billion0.49% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.28MShares$1.84 Billion0.88% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $52.9B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...